This adaptation can manifest as an upregulation of anti-inflammatory factors by lung cancer cells to suppress surrounding immune cells, effectively maintaining an immunosuppressive tumor microenvironment while exploiting STING-driven inflammation to enhance invasiveness and metastasis 21, 59. Here, STING1 is linked to lung cancer.